Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Aug 22, 2024 (2 years ago)

Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02

Affected NDC 84139-0225-02

Compare with the code on your package — it is the most precise check available.

Drug: Cyanocobalamin

Recalling firm
ProRx LLC
NDC code
84139-225-02
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0654-2024 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Cyanocobalamin recalls

See all
Class II · Moderate risk

Cyanocobalamin injection USP

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Ongoing Particulate / foreign matter American Regent, Inc. NDC 0517-0032-01 D-0793-2026
Class II · Moderate risk

Cyanocobalamin injection USP

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Ongoing Particulate / foreign matter American Regent, Inc. NDC 0517-0031-01 D-0792-2026

Other recalls by ProRx LLC

All 2024 recalls